Andlauer Healthcare Group Inc.
ANDHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $2 | $2 |
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | 0.4% | -0.1% | 47.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 22.6% | 22.8% | 24.5% | 25.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 25.6% | 20.6% | 27% | 35.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 9.9% | 10.2% | 11.8% | 20.4% |
| EPS Diluted | 1.58 | 1.55 | 1.79 | 2.25 |
| % Growth | 1.9% | -13.4% | -20.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |